Close

Auxilium Pharma (AUXL) to Present Data from XIAFLEX as DC Cords Treatment

August 28, 2014 6:04 AM EDT Send to a Friend
Auxilium Pharma (Nasdaq: AUXL) announced that data from trials evaluating the use of collagenase clostridium histolyticum (CCH) for treating two ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login